Quick Answer
IMPACT BIOMEDICAL INC. reported Net Income Loss of -$11.84 million for the year ending 2025.
- IMPACT BIOMEDICAL INC. showed an increase of +52.1% in Net Income Loss from 2024 to 2025.
- This data is from IMPACT BIOMEDICAL INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: -$799.0 thousand | Q3 2022: -$2.24 million | Q1 2023: -$849.0 thousand | Q2 2023: -$1.12 million | Q3 2023: -$1.18 million | Q1 2024: -$962.0 thousand | Q2 2024: -$889.0 thousand | Q3 2024: $4.25 million | Q1 2025: -$1.27 million | Q2 2025: -$14.35 million | Q3 2025: -$1.47 million.
- Over the full 4 years of available data (2022 to 2025), IMPACT BIOMEDICAL INC.'s Net Income Loss has declined by 63.2%.
- Historical annual values: Fiscal year 2025: -$11.84 million | Fiscal year 2024: -$24.71 million | Fiscal year 2023: -$4.34 million | Fiscal year 2022: -$7.26 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: